Results 51 to 60 of about 30,580 (265)

Allergens, germs and asthma [PDF]

open access: yes, 2015
Objective To explore asthma pathogenesis using data from upper and lower airways. Data Source English-language papers on human asthma and nasal polyp subjects from 1990 onwards.
Scadding, GK
core  

Positive and negative AIT trials: What makes the difference? [PDF]

open access: yes, 2018
Background: Allergen immunotherapy has proven to be efficacious in allergic rhinitis and asthma. However, results from randomised clinical trials may vary substantially. Clinical trials may unexpectedly fail.
Gerth van Wijk, R. (Roy)
core   +4 more sources

Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Identifying predictive and monitoring biomarkers for allergen immunotherapy response is crucial for enhancing clinical efficacy. This study aims to investigate the systemic and local levels of immunoglobulins and identify potential biomarkers in house dust mite (HDM) allergic rhinitis (AR) patients who are undergoing subcutaneous ...
Xu Xu   +6 more
wiley   +1 more source

NEW LOOK ON SPECIFIC IMMUNOTHERAPY IN CHILDREN

open access: yesМедицинский совет, 2016
Objective of the Review: introduce modern ideas about the allergen-specific immunotherapy (ASIT) in children.Key Points: The article presents data about frequency of sensibilization and allergic respiratory diseases in children.
T. N. Surovenko, E. F. Glushkova
doaj   +1 more source

Immunotherapy with Pru p 3 for food allergy to peach and non-specific lipid transfer protein: a systematic review

open access: yesClinical and Molecular Allergy, 2023
Background Non-specific lipid-transfer protein (nsLTP) is a pan-allergen in the plant world, and a cause of significant concern as food allergen in the Mediterranean area, due to its general heat- and acid-resistance and hence the risk of severe allergic
Carlo Maria Rossi   +5 more
doaj   +1 more source

ALLERGEN-SPECIFIC IMMUNOTHERAPY IN CHILDREN WITH POLLINOSIS

open access: yesВопросы современной педиатрии, 2014
Aim: to compare clinical efficacy and safety of sublingual and parenteral allergen-specific immunotherapy in children with pollinosis. Patients and methods: 143 patients with pollinosis aged from 5 to 16 years old were included into the study.
R. M. Torshkhoeva   +4 more
doaj   +1 more source

The Immunological Correlation With Adenoid Hypertrophy and Allergic Rhinitis in Children

open access: yesiNew Medicine, EarlyView.
The imbalance of Th1/Th2 and Th17/Treg cells in allergen and inflammatory responses might be associated with the development of adenoid hypertrophy, suggesting that allergic rhinitis maybe the risk factor of AH and providing a potential alternative explanation for adenoid hypertrophy pathogenesis.
Yang Song   +4 more
wiley   +1 more source

Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides. [PDF]

open access: yes, 2013
BACKGROUND: Synthetic contiguous overlapping peptides (COPs) may represent an alternative to allergen extracts or recombinant allergens for allergen specific immunotherapy.
Audran, R.   +9 more
core   +1 more source

Clinical characteristics of immediate allergic adverse reactions to intravenous amoxicillin‒clavulanic acid in conscious dogs

open access: yesVeterinary Record, EarlyView.
Abstract Background Amoxicillin‒clavulanic acid (AMC) is one of the most frequently used antibiotics in small animal practice, and reports on adverse reactions are scarce. The aim of this study was to describe the clinical characteristics of immediate allergic adverse reactions to intravenous (IV) AMC in conscious dogs. Methods The medical records of a
Leonel Frutuoso, Anna Threlfall
wiley   +1 more source

Effectiveness and safety of orally administered immunotherapy for food allergies: a systematic review and meta-analysis [PDF]

open access: yes, 2013
The aim of using oral and sublingual immunotherapy with food allergies is to enable the safe consumption of foods containing these aller- gens in patients with food allergies.
Deveraux, Graham   +4 more
core   +3 more sources

Home - About - Disclaimer - Privacy